Skip to main content

Table 2 Comparison of baseline mean for BMI and serum irisin, glucose indices, and lipids in overweight or obese patients with non-alcoholic fatty liver disease (NAFLD)

From: Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial

Baseline Dependent Variables

Cardamom

(n = 43)

n(%) or Mean (SD)

Placebo

(n = 44)

n(%) or Mean (SD)

P-value

BMI (kg/m2)

25–29.99

16 (37.2)

17 (38.6)

0.8b

30–34.99

27 (62.8)

27 (61.4)

FBS (mg/dl)

93.3 (7.6)

91.5 (7.9)

0.3c

FBI (μIU/ml)

8.1 (0.6)

7.9 (0.9)

0.7c

HOMA-IR (score)

1.8 (0.1)

1.7 (0.2)

0.1a

QUICKI (score)

0.34 (0.005)

0.35 (0.008)

0.1c

Irisin (ng/ml)

25.3 (2.9)

25.2 (2.2)

1.0c

TC (mg/dl)

204.5 (25.0)

205.0 (26.7)

0.9a

TG (mg/dl)

170.2 (77.4)

178.0 (74.7)

0.6a

LDL-c (mg/dl)

125.1 (26.3)

124.4 (21.7)

0.8a

HDL-c (mg/dl)

44.7 (9.7)

45.3 (8.7)

0.7a

  1. at-test; bChi-square; cMann-Whitney; BMI body mass index, HOMA-IR homeostasis model assessment-insulin resistance, QUICKI quantitative insulin sensitivity check index, FBS fasting blood sugar, FBI fasting blood insulin, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein-cholesterol